CLL-FIT had a higher frequency of terminally differentiated NK cells characterized by NKG2Aneg/CD158b+ (Figure 3L: p = 0.047) but not NKG2Aneg/CD158a+ (Figure 3K: p = 0.09). This evidence concerns the gene KIR2DL3 and B-cell chronic lymphocytic leukemia.